AA
ANRO icon

ALPS Advisors’s Alto Neuroscience ANRO Stock Holding History

ALPS Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940K Buy
35,613
+10,325
+41% +$239K ﹤0.01% 716
2026
Q1 		$568K Sell
25,288
-217
-0.9% -$4.02K ﹤0.01% 678
2025
Q4 		$454K Buy
+25,505
New +$321K ﹤0.01% 807
2024
Q4 		– Sell
-21,309
Closed -$244K – 1044
2024
Q3 		$244K Buy
21,309
+328
+2% +$4.01K ﹤0.01% 971
2024
Q2 		$224K Buy
+20,981
New +$273K ﹤0.01% 945

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

ALPS Advisors's ANRO Position: Q2 2026 in Review

ALPS Advisors increased its Alto Neuroscience (ANRO) stake by 41% in Q2 2026, buying an estimated $239K and bringing the position to 35,613 shares worth $940K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

ALPS Advisors first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • ALPS Advisors held 35,613 shares of Alto Neuroscience worth $940K as of Q2 2026.
  • ALPS Advisors bought 10,325 Alto Neuroscience shares in Q2 2026, an estimated $239K.
  • Alto Neuroscience made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #716 holding.
  • ALPS Advisors first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.